$9.91 Billion is the total value of Orbimed Advisors's 132 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 29.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $513,152,000 | -0.5% | 8,668,100 | +11.8% | 5.18% | +36.9% |
| HCA | Buy | HCA HOLDINGS INC | $451,620,000 | -0.8% | 5,837,900 | +16.4% | 4.56% | +36.5% |
| AMGN | Buy | AMGEN INC | $416,758,000 | -5.8% | 3,013,000 | +4.6% | 4.21% | +29.6% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $393,958,000 | +2.7% | 24,007,200 | +10.7% | 3.98% | +41.2% |
| AGN | Sell | ALLERGAN PLC | $392,307,000 | -14.5% | 1,443,315 | -4.5% | 3.96% | +17.7% |
| CELG | Sell | CELGENE CORP | $388,655,000 | -12.2% | 3,593,000 | -6.1% | 3.92% | +20.7% |
| BIIB | Buy | BIOGEN INC | $381,512,000 | -26.1% | 1,307,400 | +2.2% | 3.85% | +1.6% |
| ABBV | Buy | ABBVIE INC | $377,780,000 | -15.6% | 6,943,200 | +4.2% | 3.81% | +16.1% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $348,218,000 | -5.8% | 2,226,600 | +8.9% | 3.52% | +29.6% |
| INCY | Buy | INCYTE CORP | $302,412,000 | +25.4% | 2,740,978 | +18.4% | 3.05% | +72.5% |
| IPXL | Sell | IMPAX LABORATORIES INC | $234,643,000 | -24.2% | 6,664,100 | -1.1% | 2.37% | +4.3% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $226,849,000 | -3.7% | 487,700 | +5.6% | 2.29% | +32.4% |
| MOH | Sell | MOLINA HEALTHCARE INC | $222,819,000 | -9.1% | 3,236,300 | -7.2% | 2.25% | +25.0% |
| GILD | Sell | GILEAD SCIENCES INC | $214,486,000 | -36.7% | 2,184,400 | -24.6% | 2.16% | -12.9% |
| HNT | Sell | HEALTH NET INC | $204,616,000 | -13.8% | 3,397,800 | -8.2% | 2.07% | +18.6% |
| ILMN | ILLUMINA INC | $202,369,000 | -19.5% | 1,151,000 | 0.0% | 2.04% | +10.8% | |
| COO | COOPER COS INC | $193,726,000 | -16.4% | 1,301,400 | 0.0% | 1.96% | +15.1% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $185,763,000 | -31.3% | 1,120,000 | 0.0% | 1.88% | -5.5% | |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $166,790,000 | -8.3% | 1,364,000 | -2.7% | 1.68% | +26.1% |
| T107PS | Buy | WRIGHT MED GROUP INC | $166,015,000 | +89.4% | 8,142,000 | +144.0% | 1.68% | +160.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $151,841,000 | -37.6% | 3,816,050 | -25.1% | 1.53% | -14.1% |
| RLYP | RELYPSA INC | $136,974,000 | -44.1% | 7,400,000 | 0.0% | 1.38% | -23.0% | |
| SHPG | Sell | SHIRE PLCsponsored adr | $136,355,000 | -56.8% | 664,400 | -49.1% | 1.38% | -40.5% |
| MCK | Sell | MCKESSON CORP | $129,521,000 | -19.8% | 700,000 | -2.5% | 1.31% | +10.5% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $124,156,000 | +584.3% | 2,199,000 | +616.3% | 1.25% | +842.1% |
| A | Sell | AGILENT TECHNOLOGIES INC | $121,494,000 | -14.1% | 3,539,000 | -3.5% | 1.23% | +18.1% |
| PFE | Buy | PFIZER INC | $118,196,000 | +15.5% | 3,763,000 | +23.3% | 1.19% | +58.9% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $116,979,000 | -21.8% | 11,226,400 | -9.5% | 1.18% | +7.6% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $116,343,000 | +20.8% | 2,720,200 | +77.8% | 1.17% | +66.1% |
| INSYQ | Buy | INSYS THERAPEUTICS INC NEW | $116,168,000 | +23.3% | 4,081,800 | +55.6% | 1.17% | +69.8% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $109,840,000 | -24.8% | 239,000 | -20.7% | 1.11% | +3.5% |
| ESRX | EXPRESS SCRIPTS HLDG CO | $108,648,000 | -9.0% | 1,342,000 | 0.0% | 1.10% | +25.2% | |
| LLY | New | LILLY ELI & CO | $106,454,000 | – | 1,272,000 | +100.0% | 1.08% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $101,710,000 | -37.0% | 1,188,900 | +24.1% | 1.03% | -13.3% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $101,699,000 | +15.1% | 1,105,900 | +10.0% | 1.03% | +58.5% |
| MGLN | Buy | MAGELLAN HEALTH INC | $101,603,000 | -0.0% | 1,833,000 | +26.4% | 1.03% | +37.5% |
| AGNPRA | ALLERGAN PLCpfd conv ser a | $98,309,000 | -9.8% | 104,200 | 0.0% | 0.99% | +24.0% | |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $90,093,000 | -18.0% | 1,195,500 | +27.1% | 0.91% | +12.8% |
| OPHT | Buy | OPHTHOTECH CORP | $77,940,000 | -10.6% | 1,923,500 | +14.9% | 0.79% | +23.0% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $75,002,000 | -19.9% | 1,173,000 | +47.5% | 0.76% | +10.2% |
| NUVA | NUVASIVE INC | $71,703,000 | +1.8% | 1,487,000 | 0.0% | 0.72% | +40.0% | |
| GKOS | GLAUKOS CORP | $70,101,000 | -16.5% | 2,897,937 | 0.0% | 0.71% | +14.9% | |
| TSRO | Sell | TESARO INC | $69,582,000 | -42.9% | 1,735,200 | -16.2% | 0.70% | -21.5% |
| AFFX | AFFYMETRIX INC | $64,144,000 | -21.8% | 7,511,000 | 0.0% | 0.65% | +7.6% | |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $60,668,000 | – | 2,472,200 | +100.0% | 0.61% | – |
| INSM | Buy | INSMED INC | $58,408,000 | +40.0% | 3,145,301 | +84.1% | 0.59% | +92.8% |
| ARRY | ARRAY BIOPHARMA INC | $45,876,000 | -36.8% | 10,060,500 | 0.0% | 0.46% | -13.0% | |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $41,968,000 | +8.3% | 984,700 | +15.8% | 0.42% | +49.3% |
| DNAI | New | PRONAI THERAPEUTICS INC | $40,834,000 | – | 1,989,949 | +100.0% | 0.41% | – |
| OTIC | OTONOMY INC | $40,186,000 | -22.5% | 2,256,398 | 0.0% | 0.41% | +6.6% | |
| MDT | Sell | MEDTRONIC PLC | $39,381,000 | -17.8% | 588,299 | -9.0% | 0.40% | +13.4% |
| CMRX | CHIMERIX INC | $39,025,000 | -17.3% | 1,021,600 | 0.0% | 0.39% | +13.9% | |
| LOXO | LOXO ONCOLOGY INC | $38,034,000 | -3.1% | 2,175,857 | 0.0% | 0.38% | +33.3% | |
| INFI | INFINITY PHARMACEUTICALS INC | $37,318,000 | -22.8% | 4,416,300 | 0.0% | 0.38% | +6.2% | |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $36,087,000 | – | 5,222,500 | +100.0% | 0.36% | – |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $34,456,000 | -13.7% | 377,100 | +16.0% | 0.35% | +18.8% |
| IMGN | Buy | IMMUNOGEN INC | $34,502,000 | +132.9% | 3,594,000 | +248.9% | 0.35% | +219.3% |
| EXAS | EXACT SCIENCES CORP | $31,986,000 | -39.5% | 1,778,000 | 0.0% | 0.32% | -16.8% | |
| SIEN | Sell | SIENTRA INC | $30,247,000 | -62.4% | 2,980,000 | -6.4% | 0.30% | -48.3% |
| CERS | Sell | CERUS CORP | $29,530,000 | -31.5% | 6,504,400 | -21.7% | 0.30% | -5.7% |
| VRX | VALEANT PHARMACEUTICALS INTL | $29,433,000 | -19.7% | 165,000 | 0.0% | 0.30% | +10.4% | |
| AFMD | Sell | AFFIMED N V | $28,275,000 | -63.9% | 4,582,616 | -21.2% | 0.28% | -50.4% |
| UNH | UNITEDHEALTH GROUP INC | $27,610,000 | -4.9% | 238,000 | 0.0% | 0.28% | +31.0% | |
| JNJ | Sell | JOHNSON & JOHNSON | $27,258,000 | -54.7% | 292,000 | -52.7% | 0.28% | -37.6% |
| PRQR | Buy | PROQR THRAPEUTICS N V | $26,829,000 | -12.1% | 1,841,400 | +0.5% | 0.27% | +21.0% |
| NLNK | New | NEWLINK GENETICS CORP | $25,529,000 | – | 712,306 | +100.0% | 0.26% | – |
| FWP | FORWARD PHARMA A/Ssponsored adr | $22,632,000 | -38.1% | 960,600 | 0.0% | 0.23% | -14.9% | |
| DYAX | DYAX CORP | $21,324,000 | -28.0% | 1,117,000 | 0.0% | 0.22% | -0.9% | |
| GLPG | GALAPAGOS NVspon adr | $20,880,000 | -21.0% | 512,900 | 0.0% | 0.21% | +8.8% | |
| ADRO | ADURO BIOTECH INC | $20,639,000 | -36.1% | 1,065,522 | 0.0% | 0.21% | -12.2% | |
| MRK | MERCK & CO INC NEW | $20,497,000 | -13.2% | 415,000 | 0.0% | 0.21% | +19.7% | |
| XNPT | XENOPORT INC | $20,016,000 | -43.4% | 5,768,400 | 0.0% | 0.20% | -22.0% | |
| FLDM | FLUIDIGM CORP DEL | $19,869,000 | -66.5% | 2,449,900 | 0.0% | 0.20% | -53.8% | |
| ZBH | ZIMMER BIOMET HLDGS INC | $19,941,000 | -14.0% | 212,300 | 0.0% | 0.20% | +18.2% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $19,800,000 | -23.0% | 188,000 | 0.0% | 0.20% | +5.8% | |
| CYNA | CYNAPSUS THERAPEUTICS INC | $18,439,000 | -20.8% | 1,140,325 | 0.0% | 0.19% | +8.8% | |
| SYK | STRYKER CORP | $17,503,000 | -1.5% | 186,000 | 0.0% | 0.18% | +36.2% | |
| EHTH | EHEALTH INC | $16,653,000 | +0.9% | 1,300,000 | 0.0% | 0.17% | +38.8% | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15,273,000 | -24.6% | 115,000 | 0.0% | 0.15% | +3.4% | |
| HNT | New | HEALTH NET INCcall | $15,055,000 | – | 250,000 | +100.0% | 0.15% | – |
| XNCR | Buy | XENCOR INC | $13,820,000 | -39.8% | 1,130,022 | +8.2% | 0.14% | -16.7% |
| NTRA | New | NATERA INC | $13,847,000 | – | 1,276,190 | +100.0% | 0.14% | – |
| SVA | SINOVAC BIOTECH LTD | $13,551,000 | -3.2% | 2,667,500 | 0.0% | 0.14% | +33.0% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $13,356,000 | -50.4% | 1,397,100 | 0.0% | 0.14% | -31.5% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $13,285,000 | -33.5% | 7,259,620 | 0.0% | 0.13% | -8.2% | |
| NBRV | New | NABRIVA THERAPEUTICS AGsponsored adr | $12,493,000 | – | 1,315,000 | +100.0% | 0.13% | – |
| SGYPQ | Sell | SYNERGY PHARMACEUTICALS DEL | $12,066,000 | -53.4% | 2,276,648 | -27.1% | 0.12% | -35.8% |
| VRTX | VERTEX PHARMACEUTICALS INC | $11,976,000 | -15.7% | 115,000 | 0.0% | 0.12% | +16.3% | |
| CAH | CARDINAL HEALTH INC | $11,216,000 | -8.2% | 146,000 | 0.0% | 0.11% | +25.6% | |
| ENSG | ENSIGN GROUP INC | $10,555,000 | -16.5% | 247,600 | 0.0% | 0.11% | +15.1% | |
| BAX | New | BAXTER INTL INC | $10,479,000 | – | 319,000 | +100.0% | 0.11% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $9,825,000 | – | 114,000 | +100.0% | 0.10% | – |
| INCYTE CORPnote 1.250%11/1 | $9,403,000 | +7.9% | 4,250,000 | 0.0% | 0.10% | +48.4% | ||
| CLLS | CELLECTIS S Asponsored ads | $9,226,000 | -26.9% | 350,000 | 0.0% | 0.09% | 0.0% | |
| BXLT | New | BAXALTA INC | $8,980,000 | – | 285,000 | +100.0% | 0.09% | – |
| INCYTE CORPnote 0.375%11/1 | $8,979,000 | +4.1% | 4,250,000 | 0.0% | 0.09% | +44.4% | ||
| ABT | ABBOTT LABS | $8,486,000 | -18.1% | 211,000 | 0.0% | 0.09% | +13.2% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $8,261,000 | -61.4% | 240,000 | -64.7% | 0.08% | -47.1% |
| CNXR | CONNECTURE INC | $7,934,000 | -56.8% | 1,740,000 | 0.0% | 0.08% | -40.7% | |
| RDHL | REDHILL BIOPHARMA LTDsponsored ads | $7,293,000 | -26.7% | 564,900 | 0.0% | 0.07% | +1.4% | |
| MCRB | SERES THERAPEUTICS INC | $7,311,000 | -28.6% | 246,645 | 0.0% | 0.07% | -1.3% | |
| AET | Sell | AETNA INC NEW | $7,330,000 | -40.1% | 67,000 | -30.2% | 0.07% | -17.8% |
| Sell | FLUIDIGM CORP DELnote 2.750% 2/0 | $7,154,000 | -31.2% | 10,000,000 | -16.2% | 0.07% | -5.3% | |
| MGNX | MACROGENICS INC | $6,790,000 | -43.6% | 317,000 | 0.0% | 0.07% | -21.6% | |
| ADXS | Sell | ADVAXIS INC | $6,512,000 | -57.6% | 636,600 | -15.7% | 0.07% | -41.6% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $6,348,000 | -42.0% | 149,999 | -0.0% | 0.06% | -20.0% |
| ANAC | Sell | ANACOR PHARMACEUTICALS INC | $6,274,000 | -37.2% | 53,300 | -58.7% | 0.06% | -13.7% |
| ROKA | ROKA BIOSCIENCE INC | $6,280,000 | -25.0% | 3,220,429 | 0.0% | 0.06% | +3.3% | |
| LBIO | LION BIOTECHNOLOGIES INC | $5,887,000 | -37.2% | 1,022,100 | 0.0% | 0.06% | -14.5% | |
| IMMU | New | IMMUNOMEDICS INC | $5,716,000 | – | 3,323,000 | +100.0% | 0.06% | – |
| HZNP | Sell | HORIZON PHARMA PLC | $4,043,000 | -87.8% | 204,000 | -78.5% | 0.04% | -83.1% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $3,933,000 | -84.6% | 222,223 | -84.7% | 0.04% | -78.7% |
| ITEK | New | INOTEK PHARMACEUTICALS CORP | $3,995,000 | – | 425,000 | +100.0% | 0.04% | – |
| VTAE | New | VITAE PHARMACEUTICALS INC | $3,980,000 | – | 361,500 | +100.0% | 0.04% | – |
| OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $3,621,000 | -25.9% | 5,210,000 | 0.0% | 0.04% | +2.8% | ||
| FATE | FATE THERAPEUTICS INC | $3,693,000 | -17.6% | 692,900 | 0.0% | 0.04% | +12.1% | |
| BITI | BIOTIE THERAPIES OYJsponsored adr | $3,517,000 | -34.4% | 268,672 | 0.0% | 0.04% | -7.7% | |
| PTX | PERNIX THERAPEUTICS HLDGS IN | $3,391,000 | -46.6% | 1,073,000 | 0.0% | 0.03% | -27.7% | |
| ALIM | ALIMERA SCIENCES INC | $3,315,000 | -52.1% | 1,500,000 | 0.0% | 0.03% | -35.3% | |
| NVTA | INVITAE CORP | $3,297,000 | -51.5% | 456,666 | 0.0% | 0.03% | -34.0% | |
| OCUL | New | OCULAR THERAPEUTIX INC | $2,937,000 | – | 208,900 | +100.0% | 0.03% | – |
| MDGS | New | MEDIGUS LTDsponsored adr | $2,688,000 | – | 600,000 | +100.0% | 0.03% | – |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $2,112,000 | -97.4% | 176,470 | -96.0% | 0.02% | -96.5% |
| BLRX | Sell | BIOLINERX LTDsponsored adr | $1,589,000 | -47.4% | 1,038,600 | -8.5% | 0.02% | -27.3% |
| XTNT | New | XTANT MEDICAL HOLDINGS INC | $1,550,000 | – | 475,439 | +100.0% | 0.02% | – |
| MNKD | MANNKIND CORPput | $1,445,000 | -43.6% | 450,000 | 0.0% | 0.02% | -21.1% | |
| QLTI | QLT INC | $1,330,000 | -35.6% | 500,000 | 0.0% | 0.01% | -13.3% | |
| CGNT | COGENTIX MED INC | $1,229,000 | -23.4% | 990,745 | 0.0% | 0.01% | 0.0% | |
| AMRN | AMARIN CORP PLCspons adr new | $676,000 | -21.5% | 350,000 | 0.0% | 0.01% | +16.7% | |
| BIOMARIN PHARMACEUTICAL INCnote 1.500%10/1 | $653,000 | -17.6% | 500,000 | 0.0% | 0.01% | +16.7% | ||
| BIOMARIN PHARMACEUTICAL INCnote 0.750%10/1 | $653,000 | -15.3% | 500,000 | 0.0% | 0.01% | +16.7% | ||
| ALIM | New | ALIMERA SCIENCES INCcall | $442,000 | – | 200,000 | +100.0% | 0.00% | – |
| VTL | Exit | VITAL THERAPIES INCput | $0 | – | -75,000 | -100.0% | -0.01% | – |
| CEMP | Exit | CEMPRA INC | $0 | – | -50,000 | -100.0% | -0.01% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DELcall | $0 | – | -250,000 | -100.0% | -0.02% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -141,900 | -100.0% | -0.02% | – |
| EBIO | Exit | ELEVEN BIOTHERAPEUTICS INC | $0 | – | -731,600 | -100.0% | -0.02% | – |
| PDLI | Exit | PDL BIOPHARMA INCcall | $0 | – | -380,000 | -100.0% | -0.02% | – |
| PTCT | Exit | PTC THERAPEUTICS INCput | $0 | – | -50,000 | -100.0% | -0.02% | – |
| ARRY | Exit | ARRAY BIOPHARMA INCcall | $0 | – | -500,000 | -100.0% | -0.03% | – |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES INcall | $0 | – | -250,000 | -100.0% | -0.03% | – |
| IPXL | Exit | IMPAX LABORATORIES INCcall | $0 | – | -150,000 | -100.0% | -0.05% | – |
| AGN | Exit | ALLERGAN PLCcall | $0 | – | -25,000 | -100.0% | -0.06% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -1,550,300 | -100.0% | -0.06% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -166,500 | -100.0% | -0.07% | – |
| PODD | Exit | INSULET CORP | $0 | – | -453,000 | -100.0% | -0.10% | – |
| MRGE | Exit | MERGE HEALTHCARE INC | $0 | – | -3,308,400 | -100.0% | -0.12% | – |
| ABBV | Exit | ABBVIE INCcall | $0 | – | -300,000 | -100.0% | -0.15% | – |
| Exit | INCYTE CORPnote 4.750%10/0 | $0 | – | -2,742,000 | -100.0% | -0.24% | – | |
| BMY | Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -500,000 | -100.0% | -0.24% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -200,000 | -100.0% | -0.30% | – |
| RCPT | Exit | RECEPTOS INC | $0 | – | -628,100 | -100.0% | -0.88% | – |
| TRNX | Exit | TORNIER N V | $0 | – | -4,805,000 | -100.0% | -0.88% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -1,413,400 | -100.0% | -1.18% | – |
| BONE | Exit | Bacterin International Holdings Inc | $0 | – | -475,439 | -100.0% | -12.21% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2015-11-18
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.